Letter to the editor: Relevance of population-based cutoffs to define frailty in clinical studies
- PMID: 35006628
- DOI: 10.1002/hep.32321
Letter to the editor: Relevance of population-based cutoffs to define frailty in clinical studies
Comment in
-
Reply.Hepatology. 2022 Apr;75(4):1068-1069. doi: 10.1002/hep.32325. Epub 2022 Jan 27. Hepatology. 2022. PMID: 35006612 No abstract available.
Comment on
-
Frailty is associated with increased risk of cirrhosis disease progression and death.Hepatology. 2022 Mar;75(3):600-609. doi: 10.1002/hep.32157. Epub 2021 Dec 5. Hepatology. 2022. PMID: 34528267
References
-
- Wang S, Whitlock R, Xu C, Taneja S, Singh S, Abraldes JG, et al. Frailty is associated with increased risk of cirrhosis disease progression and death. Hepatology. 2021. https://doi.org/10.1002/hep.32157 - DOI
-
- Singh SA, Madan K, Rastogi R, Agarwal AR, Gupta S, Thakur R. Relevance of population‐based cutoffs to define sarcopenia in clinical studies. J Clin Exp Hepatol. 2021;11:276–7.
-
- Chen L‐K, Woo J, Assantachai P, Auyeung T‐W, Chou M‐Y, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Ass. 2020;21:300–7.e2.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
